Table 4 Additional vaccinations received by IBD cohort (N = 69)
From: Immunisation status of children and adolescents with a new diagnosis of inflammatory bowel disease
| Â | Received after IBD diagnosis and before SIC review n (%) | Received within 12 months of SIC review n (%) | Received any time since IBD diagnosis n (%) |
|---|---|---|---|
Any vaccination | 33 (47.8%) | 64 (92.8%) | 67 (97.1%) |
Any pneumococcal vaccination | 6 (8.7%) | 59 (85.5%) | 63 (91.3%) |
 PCV | 6 (8.7%) | 53 (76.8%) | 59 (85.5%) |
 PPV | 1 (1.4%) | 38 (55.1%) | 39 (56.5%) |
Influenza | 17 (24.6%) | 48 (69.6%) | 55 (79.7%)a |
VZV | 11 (15.9%) | 18 (26.1%) | 29 (42%) |
MMR | 6 (8.7%) | 16 (23.3%) | 22 (31.9%) |
HPV | 12 (17.4%) | 19 (27.5%) | 25 (36.2%)a |
dTap | 13 (18.8%) | 17 (24.6%) | 30 (43.5%) |
HBV | 3 (4.3%) | 27 (39.1%) | 29 (42%)a |
HAV | 6 (8.7%) | 36 (52.2%) | 37 (53.6%)a |
Meningococcal ACWY | 1 (1.4%) | 15 (21.7%) | 16 (23.2%) |
Meningococcal B | 0 | 19 (27.5%) | 19 (27.5%) |
Other | 7b (10.1%) | 3c (4.3%) | 10 (14.5%) |
Total vaccinations (median; IQR) | 84 (0; 0–2) | 307 (5, 3–6) | 391 (5; 4–7) |
Completed SIC recommended schedule within 12 months | 30 (43.5%) | ||